Bioequivalence Trial of Alprazolam 0.25 mg Tablets

Clinical trial NCT01853956 · COMPLETED

Trial details

NCT number: NCT01853956
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2010-12-02
Primary completion: 2010-12-10
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.